• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Chinese Weekly Influenza Surveillance Report - Chinese National Influenza Center - for trend analysis only

Mary Wilson

Well-known member

Chinese Weekly Influenza Surveillance Report

January 6 to 12, 2025 (Week 2)

(All data are preliminary and may change as more reports are received)

Summary

 Influenza detections increased in the southern provinces, declined in northern

provinces in this week. A(H1N1)pdm09 was predominated. There were 118 ILI

outbreaks reported in week 2.

 Among influenza viruses antigenically characterized by CNIC since April 1,

2024, 2130(96.9%) influenza A(H1N1)pdm09 viruses were characterized as

A/Victoria/4897/2022-like; 411(56.8%) influenza A(H3N2) viruses were

characterized as A/Thailand/8/2022(egg)-like, 473(65.4%) influenza A(H3N2)

viruses were characterized as A/Thailand/8/2022(cell)-like; 1009(98.9%)

influenza B/Victoria viruses were characterized as B/Austria/1359417/2021-like.

 Among the influenza viruses tested by CNIC for antiviral resistance analysis

since April 1, 2024, all but 57influenza A(H1N1)pdm09 were sensitive to

neuraminidase inhibitors, all A(H3N2) and B viruses were sensitive to

neuraminidase inhibitors; all A(H1N1)pdm09, A(H3N2) and B viruses were

sensitive to endonuclease inhibitors. ...

https://ivdc.chinacdc.cn/cnic/en/Surveillance/WeeklyReport/202501/P020250116400892864828.pdf
 
WHO Collaborating Center for Reference and Research on Influenza
Chinese National Influenza Center
National Institute for Viral Disease Control and Prevention, China CDC


Chinese Weekly Influenza Surveillance Report

January 13 to 19, 2025 (Week 3)
(All data are preliminary and may change as more reports are received)

Summary

⚫ Influenza detections declined in the southern provinces and northern provinces.

A(H1N1)pdm09 was predominated. There were 20 ILI outbreaks reported in

week 3.

⚫ Among influenza viruses antigenically characterized by CNIC since April 1,

2024, 2383(97.1%) influenza A(H1N1)pdm09 viruses were characterized as

A/Victoria/4897/2022-like; 411(56.8%) influenza A(H3N2) viruses were

characterized as A/Thailand/8/2022(egg)-like, 473(65.4%) influenza A(H3N2)

viruses were characterized as A/Thailand/8/2022(cell)-like; 1009(98.9%)

influenza B/Victoria viruses were characterized as B/Austria/1359417/2021-like.

⚫ Among the influenza viruses tested by CNIC for antiviral resistance analysis

since April 1, 2024, all but 63 influenza A(H1N1)pdm09 were sensitive to

neuraminidase inhibitors, all A(H3N2) and B viruses were sensitive to

neuraminidase inhibitors; all A(H1N1)pdm09, A(H3N2) and B viruses were

sensitive to endonuclease inhibitors. ...

https://ivdc.chinacdc.cn/cnic/en/Surveillance/WeeklyReport/202501/P020250122525335262720.pdf



 
Back
Top Bottom